Bendamustine Hydrochloride (CAS-3543-75-7) in bulk from. The subject product, Bendamustine Hydrochloride, is a chemotherapy agent. It is indicated for the treatment of chronic lymphocytic leukemia and in patients with indolent B-cell non-Hodgkin's lymphoma that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.
[1] Please importantly note that only the relevant portion of the related is displayed above. You may refer to the said customs ruling for the entire ruling explanation.
[1]. https://rulings.cbp.gov/ruling/N062257